Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you. I already placed an order for the products. Loved these pills.
There is a description and apparent ability to purchase this product at
www.pluripain.com
Otherwise they list this contact info:
(877) 252 – 8282
info@bioadaptives.com
SOMETHING IS COOKING .
I could smell it.😂
let's hope we get some kind of a recovery, will see
Those of us who've lost a metric ton of money here haven't forgotten...Sigh...
Thank you. Appreciated.
They developed a new website. I can no longer purchase this product called PluriPain. Does anyone here know where I can find this amazing PluriPain?
????? Dilution??? As 2 bill?
Fake society!
That would be nice, I was just expecting this New Management to do a little more. At least say something.
Good. Havn’t forgot about it enough to let me get my damn .0001s yet tho
wow 39 volume' looks like everyone has forgot about this failure
Good, this stock needs some serious help. Investors not happy about stock’s performance, straight up awful.
Either this guy is out of his mind to join BDPT or they have something really special we don’t know about it yet!
Wait game!
At least no dilution for a while now
Hopefully it only gets better from now on.
BDPT Welcomes Gimhana Dissanayake to Its Board of Directors...
This is more solid news for BDPT as a guy of this caliber would not be joining this team for something small in my opinion:
lol. You mean the new story to lure the sheep in? Hahaha.
More possible now then before
Great. Can we get out of trips now?
This new CEO James Keener, hopefully can bring in some institutional investors and more Capital possibly through his connections. will see
James Keener, recently appointed as the Chief Executive Officer of BioAdaptives, Inc., BDPT, brings a wealth of experience spanning nearly three decades. His entrepreneurial journey has traversed various sectors, including real estate, agricultural science, hospitality, construction, and maintenance systems, equipping him with a multifaceted perspective on business and innovation.
As a dynamic leader, Keener has earned a sterling reputation for cultivating a culture of productivity and enthusiasm among stakeholders, consistently delivering exceptional outcomes. He is particularly noted for his role as a turnaround specialist, adept at transforming underperforming ventures into profitable enterprises.
Before his tenure at BioAdaptives, Keener honed his strategic acumen first as a consultant and subsequently as the CEO of a family office investment fund. There, he skillfully managed diversified holdings in real estate, business investment, agriculture, retail, and internet marketing, proving his ability to oversee and expand complex portfolios effectively.
Keener's entrepreneurial prowess is best demonstrated by the specialized construction and maintenance company he founded, which, under his guidance, achieved remarkable growth. It was acknowledged as the fastest-growing company in all sectors across the Hawaiian islands in 2019 and continued its upward trajectory into 2020.
In his new role at BioAdaptives, Keener is poised to leverage his extensive experience in operational transformation to drive innovation and growth within the advanced nutrition and wellness solutions sector. His leadership comes at a crucial juncture for the company, which is on the brink of expanding its influence in the market of high-quality wellness and nutritional products, catering to a diverse range of consumer needs, including both human and animal health.
Under Keener’s guidance, BioAdaptives is set to redefine industry standards by elevating the research and development of nutritional solutions, thereby enhancing health and wellness globally. He officially assumed his role as CEO on May 21, 2024, and is unwavering in his commitment to expanding BioAdaptives' product offerings and market presence, while nurturing a team of exceptional talent.
https://www.shopbioadaptives.com/pages/investors
This is good news that finally got rid of the old ducks.
“BioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives
LAS VEGAS, NV - (NewMediaWire) - May 21, 2024 - BioAdaptives, Inc. (OTC: BDPT), a pioneer in advanced nutrition and wellness solutions, announced a significant addition to its Executive Team today. James Keener has been appointed the new CEO and will play a pivotal role in driving the company's strategic initiatives and fostering continued growth.
BioAdaptives announced today that James Keener, a seasoned marketing and turnaround innovative executive, had taken over as the new Chief Executive Officer and Chairman of the Board of the Company. Among his various endeavors, Mr Keener brings a wealth of experience and expertise to BioAdaptives. He has led a specialized construction and maintenance company to become the fastest-growing company in Hawaii for 2019/2020, a testament to his ability to drive growth. He has also successfully turned around a private investment company with diverse real estate, agriculture, retail, and Internet marketing holdings, demonstrating his strategic thinking and leadership. Mr. Keener's past successes instill optimism for BioAdaptives' future and underline his potential to drive the Company's growth.
Dr. Edward Jacobs, former CEO, said, "After personally devoting a decade to discovery and product development at BioAdaptives, I look forward to the new leadership of James Keener, which will focus more on sales and distribution. I understand that Mr. Keener enjoys a reputation as an innovative Marketer with expertise in helping companies increase Revenues and Profits." Outgoing President Robert Ellis adds, "The company is extremely happy in anticipation of Mr. Keener's strong and varied executive management leadership and innovation, especially in the areas of marketing and sales development and expansion. We wish the New Management Team well in achieving their goals and objectives for BioAdaptives."
"BioAdaptives extends its good wishes and appreciation to both Dr. Jacobs and Mr. Ellis for their many years of dedicated work. The Company fully appreciates the personal and family demands that required their new focus," said Mr. James Keener. "I am honored to be part of BioAdaptives and am excited to get to work applying my extensive experience in operational transformation to another exciting sector."
Mr.Keener adds, "I am committed to leveraging our core strengths and unlocking new opportunities for innovation and growth, aligning with our mission to improve health and wellness through high-quality, research-driven nutritional products; together, we will continue to enhance our product offerings and expand our market footprint."
$BDPT
carusso...
I'm just holding and hoping that the CEO given his qualifications would not be here keeping BDPT current with it SEC filing if he had no plan to eventually move forward.
v/r
Sterling
I don't know what will happen here...sorry I can't give you a better insight
Care to share your views on the future of this company?
Thanks for posting that…
Does this still have a detectable pulse?
Hopefully INTHEKNOW1 got rid of all his shares coming to an end now.
More dilution with over a billion shares now. More losses, no money, no prospects. Downward trend likely to continue.
It looks like they pulled through on the 10Q.
https://ih.advfn.com/stock-market/USOTC/bioadaptives-pk-BDPT/stock-news/93882024/form-10-q-quarterly-report-sections-13-or-15d
Aren’t you a sight for sore eyes. Good to see you on board.
That is hilarious - they have a new auditor because Borgers is a prohibited service provider.
"SEC Charges Audit Firm BF Borgers with Fraud"
The question is why did BDPT use a fraudulent auditor?
You didn't mention that BDPT is listed as a Shell Risk.
The Securities Counsel Donald Keer doesn't have many reputable clients on the OTC.
IG
That would be ideal
Give me no bid .0001s
Thanks stervc
$BDPT
Followers
|
231
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
21238
|
Created
|
07/08/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |